ANAPHYLATOXINS IN DILATED CARDIOMYOPATHY

被引:5
|
作者
SAMSONOV, M [1 ]
NASSONOV, E [1 ]
MASENKO, V [1 ]
NAUMOV, V [1 ]
MAREEV, V [1 ]
BELENKOV, Y [1 ]
机构
[1] CARDIOL RES CTR,INST CARDIOL,CLIN IMMUNOL LAB,MOSCOW,RUSSIA
关键词
ANAPHYLATOXINS; DILATED CARDIOMYOPATHY; THROMBOEMBOLIC COMPLICATIONS;
D O I
10.1111/j.1365-2796.1993.tb00722.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objects. The aim of the study was to investigate the possible relationship between activation of complement system and thromboembolic complications in dilated cardiomyopathy (DCMP). Methods. The plasma C3a and C5a concentrations were determined by radioimmunoassay measurement (Amersham International, UK) in 23 patients with DCMP, 9 with hypertrophic cardiomyopathy (HCMP) and 11 healthy volunteers. Results. The mean C3a concentration was significantly higher in DCMP patients (5 72 +/- 55 ng ml-1) compared with hypertrophic cardiomyopathy (344 +/- 30 ng ml-1) and with healthy controls (294 +/- 43 ng ml-1) (P<0.001). There were no significant correlations for C5a concentrations in this group. Mean C3a concentration in DCMP patients with thromboembolic complications (736 +/- 95 ng ml-1) was also significantly higher compared with DCMP patients without these complications (344 +/- 14 ng ml-1) (P<0.001). Conclusions. We conclude that anaphylatoxins may play a role in the pathogenesis of thromboembolic complications.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [1] Dilated cardiomyopathy
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (04) : 350 - 350
  • [2] Dilated cardiomyopathy
    Sommerfield, R
    Kamat, D
    CLINICAL PEDIATRICS, 2004, 43 (02) : 209 - 212
  • [3] Dilated cardiomyopathy
    Heinz-Peter Schultheiss
    DeLisa Fairweather
    Alida L. P. Caforio
    Felicitas Escher
    Ray E. Hershberger
    Steven E. Lipshultz
    Peter P. Liu
    Akira Matsumori
    Andrea Mazzanti
    John McMurray
    Silvia G. Priori
    Nature Reviews Disease Primers, 5
  • [4] Dilated cardiomyopathy
    Weintraub, Robert G.
    Semsarian, Christopher
    Macdonald, Peter
    LANCET, 2017, 390 (10092): : 400 - 414
  • [5] DILATED CARDIOMYOPATHY
    GOTTLIEB, SS
    CURRENT OPINION IN CARDIOLOGY, 1993, 8 (03) : 441 - 446
  • [6] Dilated cardiomyopathy
    Burch, M
    Runciman, M
    ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (06) : 479 - 481
  • [7] DILATED CARDIOMYOPATHY
    ALNOZHA, M
    ANNALS OF SAUDI MEDICINE, 1990, 10 (02) : 127 - 128
  • [8] DILATED CARDIOMYOPATHY
    WEBBPEPLOE, M
    EUROPEAN HEART JOURNAL, 1984, 5 : 161 - 164
  • [9] DILATED CARDIOMYOPATHY
    SOTOS, JG
    LEVIN, HR
    BAUGHMAN, KL
    CURRENT OPINION IN CARDIOLOGY, 1992, 7 (03) : 429 - 438
  • [10] DILATED CARDIOMYOPATHY
    FIGULLA, HR
    WIEGAND, V
    KREUZER, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (02) : 66 - 70